China SXT Pharmaceuticals (SXTC) Invested Capital (2018 - 2025)
Historic Invested Capital for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $4475.0.
- China SXT Pharmaceuticals' Invested Capital fell 9993.99% to $4475.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year decrease of 1592.74%. This contributed to the annual value of $15.4 million for FY2025, which is 710.68% up from last year.
- Per China SXT Pharmaceuticals' latest filing, its Invested Capital stood at $4475.0 for Q3 2025, which was down 9993.99% from $15.4 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Invested Capital ranged from a high of $28.1 million in Q1 2021 and a low of $4475.0 during Q3 2025
- For the 5-year period, China SXT Pharmaceuticals' Invested Capital averaged around $10.4 million, with its median value being $10.9 million (2024).
- In the last 5 years, China SXT Pharmaceuticals' Invested Capital skyrocketed by 19833.85% in 2024 and then crashed by 9993.99% in 2025.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Invested Capital stood at $2.1 million in 2021, then tumbled by 43.04% to $1.2 million in 2022, then surged by 106.96% to $2.5 million in 2023, then surged by 198.34% to $7.4 million in 2024, then plummeted by 99.94% to $4475.0 in 2025.
- Its last three reported values are $4475.0 in Q3 2025, $15.4 million for Q1 2025, and $7.4 million during Q3 2024.